The Advisory Committee on Vaccines (ACV) provides independent medical and scientific advice to the Minister for Health and the Therapeutic Goods Administration (TGA) on issues relating to the safety, quality and efficacy of vaccines supplied in Australia. This includes issues relating to pre-market assessment, post-market monitoring and safe use through the National Immunisation Program.

The ACV is established under Regulation 39F of the Therapeutic Goods Regulations 1990. Members are appointed by the Minister for Health.

The ACV was established in January 2017, following consolidation of previous functions of the Advisory Committee on the Safety of Vaccines (ACSOV) and the pre-market functions for vaccines of the Advisory Committee on Prescription Medicines (ACPM).


Membership includes professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.

The Therapeutic Goods Administration has more information on the ACV including its membership and meeting details.


Advisory Committee on Vaccines

Contact the secretariat for the Advisory Committee on Vaccines (ACV) for further information on the committee or previous meeting minutes and agendas

acv [at]
Postal address: 
MDP 71
GPO Box 9848
Canberra ACT 2601

View contact

Last updated: 
23 May 2018